The Latest

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

Nyxoah to Release Third Quarter Financial Results on November 8, 2022 Mont-Saint-Guibert, Belgium – October 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the […]
October 19, 2022

Nyxoah to Release Third Quarter Financial Results on November 8, 2022

Mont-Saint-Guibert, Belgium – October 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the third quarter of 2022 on Tuesday, November 8, 2022, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

Investors interested in listening to the conference call may do so by registering for a unique personal PIN at the following link: https://register.vevent.com/register/BI0d7e0daed6e34e548b85e51146400c1a. A live and archived webcast of the event will be available on the Company’s investor relations website at https://investors.nyxoah.com/events.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment

Total
0
Shares
Share
Tweet
Previous Article

‫الاختبار المنزلي للأجسام المضادة لكوفيد-19iStatis من شركة bioLytical Laboratories Inc يحصل على التأهيل المسبق من منظمة الصحة العالمية

Next Article

LeddarTech Brings Raw Data Fusion and Perception Software Technology to November Automotive Events in Motor City Detroit

Related Posts

Huawei Builds an iSuperSite Showcase in Collaboration with China Mobile Zhejiang and the China Mobile Design Institute

SHENZHEN, China, Nov. 15, 2021 /PRNewswire/ — Huawei’s iSuperSite showcase, a joint venture with China Mobile Zhejiang and the China Mobile Design Institute in Hangzhou, has recently been accepted. The site has been upgraded with the Huawei iSuperSite solution since August of this year. The original six cabinets were replaced by just one, minimizing grid […]

NEW OPTASIA AIRTIME ADVANCE SERVICES DEPLOYMENT IN MYANMAR

DUBAI, UAE, Feb. 7, 2023 /PRNewswire/ — Optasia, a leading Fintech services provider, is pleased to announce the deployment of its Airtime Advance solutions in Myanmar in collaboration with its partner Aljabor Technologies, through the network of Ooredoo, a major telecommunications provider in the country. The Airtime Advance service powered by Optasia is offered in […]

Winners of the EFQM business transformation awards announced at the 2nd Edition Of The EFQM The Middle East Summit “Shaping the Future Through Excellence, Agility and Sustainable Transformation”

 Majed Rafed Al-Argoubi, CEO of Saudi Authority for Industrial Cities and Technology Zones, (MODON), Dr. Sulaiman Al Habib Medical Group and  Dubai Police,  Win EFQM Transformation Awards. ABU DHABI, UAE – African Media Agency – 16 October 2023 – Abu Dhabi, October 12th – EFQM wraps up its second edition of the Middle East Summit […]